ENB-003

DB17340InvestigationalSmall molecule

ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer.

Mechanism: Pharmacologically active on Endothelin receptor type B
Curator reviewed
Also known as: sodium bispiperidine-carboxamido-dimethylpenatnamido-methoxycarbonyl-indol-propanamidohexanoate
Code names: ENB-003

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with ENB-003, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.